Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
TRACON Pharmaceuticals Announces Acceptance of the Envafolimab (KN035) NDA by the NMPA in China that was Submitted by its Corporate Partners Alphamab Oncology and 3D Medicines
SAN DIEGO, Dec.
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B
GAITHERSBURG, Md.
Protalix's Fabry Disease Treatment Hits the Mark in Phase III Switch-Over Study
Shares of Protalix Biotherapeutics were up nearly 7% in premarket trading after the company announced its Phase III BRIDGE study met key objectives in treating Fabry Disease.
UK Government Authorizes AstraZeneca’s COVID-19 Vaccine for Emergency Use
Residents of the United Kingdom now have a second vaccine against the novel coronavirus, even as a more virulent strain of COVID-19 sweeps across its lands.
Aprea Therapeutics Closes Out 2020 with Phase III Flop
Shares of Aprea Therapeutics plunged more than 77% in morning trading after the Boston-based company announced its late-stage cancer combination treatment failed to meet its primary endpoint of co...
LA residents can use their phones to provide COVID-19 vaccination proof
After seeing record COVID-19 deaths and hospitalizations, Los Angeles County will use technology to help residents track and prove their vaccination records, Bloomberg reports.
Large transporter protein linked to schizophrenia
Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens.
Drugmakers agree to halve prices to get on China state insurance list
BEIJING (Reuters) - Drugmakers have agreed to cut prices by around 50% on average for more than 100 medicines in order to have them included in China’s state medical insurance scheme fro...
Voyager Takes a Hit After FDA Places Hold on Gene Therapy for Parkinson's Disease
Shares of Voyager Therapeutics were down nearly 10% in premarket trading after the company announced the U.
AstraZeneca Could Get Green Light in UK and Other COVID-19 Vaccine News
The United States now has two authorized vaccines in its arsenal against the novel coronavirus and additional preventative medications are expected to come on line within the next few weeks and months...
Iowa State University Approaches COVID-19 Using Nanotechnology
The World Health Organization (WHO) indicates there are more than 50 COVID-19 vaccine candidates in clinical trials—the specific number is typically around 74, although other sources cite mo...
Myovant and Pfizer Ink $4.2 Billion Deal for Orgovyx in Prostate Cancer and Women's Health
Myovant Sciences’ stock rocketed 22% on news it was partnering with Pfizer to develop and commercialize relugolix for prostate cancer and women’s health.
1
2
3
4
5
